Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
Podcast: AI in stroke - Using deep learning to predict clinical outcomes after stroke
jan 2024 | Neuro-vasculair